AVTX vs ED · P/E 0.0, rev $441.0K vs P/E 18, rev $15.26B
Avalo Therapeutics Inc (AVTX) versus Consolidated Edison Inc (ED) — a side-by-side from cached financials, not a winner call.
Avalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Latest reported AVTX revenue for 2024-12-31 was $441.0K. Net income was -$35.1M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AVTX currently screens at market cap $51.5M and trailing P/E 0.0.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
AVTX currently screens at market cap $51.5M and trailing P/E 0.0. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Not investment advice. Open the AVTX and ED stock pages for the full models.
Not investment advice.